Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 21Sarcoma 8Other solid neoplasm 5Genitourinary 4Gastrointestinal 3Lymphoid 2Gynecologic 2Other hematologic neoplasm 1Head & Neck 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 55Leukemia, Myeloid, Acute 44Myelodysplastic Syndromes 39Lymphoma, Non-Hodgkin 34Lymphoma 32Leukemia 31Leukemia, Myelogenous, Chronic, BCR-ABL Positive 22Hodgkin Disease 19Leukemia, Lymphocytic, Chronic, B-Cell 17Burkitt Lymphoma 15Multiple Myeloma 12Lymphoma, Large B-Cell, Diffuse 12Leukemia, Biphenotypic, Acute 12Leukemia, Myeloid, Accelerated Phase 11Lymphoma, Large-Cell, Immunoblastic 10Lymphoma, Follicular 10Hematologic Neoplasms 10Dendritic Cell Sarcoma, Interdigitating 10Blast Crisis 10Lymphoma, Mantle-Cell 9Myeloproliferative Disorders 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Myeloid, Chronic-Phase 8Graft vs Host Disease 8Anemia, Refractory, with Excess of Blasts 8Leukemia, Myelomonocytic, Juvenile 7Congenital Abnormalities 7Recurrence 6Lymphoma, Large-Cell, Anaplastic 6Waldenstrom Macroglobulinemia 5

Interventions

Temozolomide 9Filgrastim 7Specimen Handling 6X-Rays 5Rituximab 5Radiotherapy 5Phantoms, Imaging 5Magnetic Resonance Spectroscopy 5Psychiatric Rehabilitation 4Nuclear Medicine Department, Hospital 4Methotrexate 4Etoposide 4Cyclophosphamide 4Biopsy 4etoposide phosphate 3Pemetrexed 3Melphalan 3Cytarabine 3Carboplatin 3tazemetostat 2sargramostim 2olaparib 2larotrectinib 2erdafitinib 2ensartinib 2Vincristine 2Vemurafenib 2Topotecan 2Thiotepa 2Peripheral Blood Stem Cell Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Thiotepa × Lymphoid × Clear all
NCT00621036 2018-11-26

Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma

University of Texas Southwestern Medical Center

Phase 2 Withdrawn
CNSDermatologicLymphoidOther hematologic neoplasm

Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Central Nervous System Neoplasms, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Intraocular Lymphoma

NCT00007982 2013-02-04

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled
CNSHead & NeckLymphoid

Astrocytoma, Brain Neoplasms, Head and Neck Neoplasms, Lymphoma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡